FindTrial
Sign In

Study on the Impact of Quadriceps Femoris Thickness Combined with Telomeres on Prognosis in Patients with Sepsis-associated Chronic Critical Illness

Study on the Impact of Quadriceps Femoris Thickness Combined with Telomeres on Prognosis in Patients with Sepsis-associated Chronic Critical Illness

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600131709
Enrollment
Unknown
Registered
2026-09-06
Start date
2026-09-09
Completion date
Unknown
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Sepsis Observation Group:None

Sponsors

The Affiliated Hospital of Jining Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. ICU admission time >= 14 days; 3. Patients who have been followed up for >= 28 days since their ICU admission; 4. The sepsis-related organ dysfunction score (SOFA) on the 14th day of admission to the department >= 2 points.

Exclusion criteria

Exclusion criteria: 1.Age > 75 years 2.Pregnant women 3.No repeated measurement of telomere length performed 4.Patients receiving immunotherapy 5.Patients with immune disorders such as malignant tumors and severe autoimmune diseases

Design outcomes

Primary

MeasureTime frame
Quadriceps Femoris Thickness;Telomere length;—

Countries

China

Contacts

Public ContactLingzhi Chen

Affiliated Hospital of Jining Medical University

15264797966@163.com+86 537 290 3633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026